Related Experiment Videos

The tumor suppression function of p21Waf is contained in its N-terminal half ('half-WAF')

R Zakut1, D Givol

  • 1Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.

Oncogene
|July 20, 1995
PubMed

Insights

The Waf-1 encoded protein, p21 (also known as cyclin-dependent kinase inhibitor 1), suppresses tumor cell growth. Its N-terminal half demonstrates superior tumor suppression compared to the full protein, suggesting gene therapy potential.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Cycle Regulation

Background:

  • The Waf-1 encoded protein, p21, is a key mediator of p53's tumor suppressor activity.
  • Overexpression of p21 in H1299 tumor cells inhibits colony formation, mirroring the effects of p53 overexpression.

Purpose of the Study:

  • To identify the specific region of the p21 protein responsible for its tumor suppressor function.
  • To investigate the structure-function relationship of p21 in inhibiting tumor cell proliferation.

Main Methods:

  • Systematic truncation of the p21 gene was performed using engineered vectors.
  • The efficiency of these truncated p21 variants in suppressing tumor cell growth was evaluated in the H1299 cell line.

Main Results:

  • The N-terminal half of the p21 molecule (residues 1-80 and 1-89) exhibited enhanced tumor cell growth suppression compared to the full-length p21 protein.
  • The C-terminal half of p21 did not demonstrate significant tumor suppressor activity.

Conclusions:

  • The N-terminal region of p21 is critical for its tumor suppressor function.
  • These findings have potential implications for developing novel gene therapy strategies for cancer treatment.

Related Concept Videos